ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633713 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633713; 2) Community: the network communities that were significantly associated with the response to NSC 633713; 3) Molecule: the relationships between components within communities and NSC 633713; 4) MDR: the compounds that were significantly associated with the NSC 633713.

NSC Compound Enrichment Correlation
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0147237897640499 0.68806861
NSC 244404 Null 0.0147237897640499 0.25974677
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.0147237897640499 0.23734889
NSC 300289 Pinafide 0.0147237897640499 0.42063639
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0147237897640499 0.67579475
NSC 371777 Null 0.0147237897640499 0.33842405
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0147237897640499 0.144073
NSC 39215 Null 0.0147237897640499 0.24993869
NSC 606497 Camptothecin Derivative 0.0147237897640499 0.48467288
NSC 63878 Cytarabine Hydrochloride AZ 0.0147237897640499 0.68010579
Total:130  Current:55    [First] [Prev] [Next] [Last]